Metabolomics for Biomarker Discovery: Moving to the Clinic

To improve the clinical course of diseases, more accurate diagnostic and assessment methods are required as early as possible. In order to achieve this, metabolomics offers new opportunities for biomarker discovery in complex diseases and may provide pathological understanding of diseases beyond tra...

Full description

Saved in:
Bibliographic Details
Published in:BioMed research international 2015-01, Vol.2015 (2015), p.1-6
Main Authors: Wang, Ping, Yan, Guangli, Sun, Hui, Zhang, Aihua, Wang, Xijun
Format: Article
Language:English
Subjects:
Advantages
Bioinformatics
Biological markers
Biomarkers
Biomedical Research
Chromatography
Disease
Genotype & phenotype
Grants
Health aspects
Humans
Mass spectrometry
Medical diagnosis
Metabolism
Metabolites
Metabolomics
Observations
Pathology
Review
Science
Scientific imaging
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c594t-b07b02b242a4bf5405e904d761af056a0bcaf072459580bad59d09f7ed4458b43
cites cdi_FETCH-LOGICAL-c594t-b07b02b242a4bf5405e904d761af056a0bcaf072459580bad59d09f7ed4458b43
container_end_page 6
container_issue 2015
container_start_page 1
container_title BioMed research international
container_volume 2015
creator Wang, Ping
Yan, Guangli
Sun, Hui
Zhang, Aihua
Wang, Xijun
description To improve the clinical course of diseases, more accurate diagnostic and assessment methods are required as early as possible. In order to achieve this, metabolomics offers new opportunities for biomarker discovery in complex diseases and may provide pathological understanding of diseases beyond traditional technologies. It is the systematic analysis of low-molecular-weight metabolites in biological samples and has become an important tool in clinical research and the diagnosis of human disease and has been applied to discovery and identification of the perturbed pathways. It provides a powerful approach to discover biomarkers in biological systems and offers a holistic approach with the promise to clinically enhance diagnostics. When carried out properly, it could provide insight into the understanding of the underlying mechanisms of diseases, help to identify patients at risk of disease, and predict the response to specific treatments. Currently, metabolomics has become an important tool in clinical research and the diagnosis of human disease and becomes a hot topic. This review will highlight the importance and benefit of metabolomics for identifying biomarkers that accurately screen potential biomarkers of diseases.
doi_str_mv 10.1155/2015/354671
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4452245</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A458161122</galeid><sourcerecordid>A458161122</sourcerecordid><originalsourceid>FETCH-LOGICAL-c594t-b07b02b242a4bf5405e904d761af056a0bcaf072459580bad59d09f7ed4458b43</originalsourceid><addsrcrecordid>eNqNkc1PGzEQxS1UBBFw6r1aqZcKFPB4be86h0oQPiUQl_Zs2bvexHSzTu1NEP89E4VGKaf4MiP55-d58wj5CvQcQIgLRkFc5ILLAvbIgOXAhxI4fNn0eX5ITlJ6oXhKkFTJA3LIsFJO2YCMnlxvbGjDzFcpa0LMrnyYmfjHxezapyosXXwbZU9h6btJ1oesn7ps3PrOV8dkvzFtcicf9Yj8vr35Nb4fPj7fPYwvH4eVULwfWlpYyizjzHDbCE6Fw7_rQoJpqJCG2gqbgnGhREmtqYWqqWoKV3MuSsvzI_JzrTtf2JmrK9f10bR6Hj3O-aaD8fr_m85P9SQsNb5nKIsCPz4EYvi7cKnXM3Tm2tZ0LiySBqmAlUoJvgtKGUiuCkS_f0JfwiJ2uAmkSs5xvXKLmpjWad81AUesVqL6Eu2BBGAMqbM1VcWQUnTNxh1QvcpZr3LW65yR_ra9kA37L1UETtfA1He1efW7qTlEXGO2YCGgoPk76Ge1oA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1684440267</pqid></control><display><type>article</type><title>Metabolomics for Biomarker Discovery: Moving to the Clinic</title><source>Wiley Online Library Open Access</source><source>Publicly Available Content Database</source><creator>Wang, Ping ; Yan, Guangli ; Sun, Hui ; Zhang, Aihua ; Wang, Xijun</creator><contributor>Che, Fa-Yun</contributor><creatorcontrib>Wang, Ping ; Yan, Guangli ; Sun, Hui ; Zhang, Aihua ; Wang, Xijun ; Che, Fa-Yun</creatorcontrib><description>To improve the clinical course of diseases, more accurate diagnostic and assessment methods are required as early as possible. In order to achieve this, metabolomics offers new opportunities for biomarker discovery in complex diseases and may provide pathological understanding of diseases beyond traditional technologies. It is the systematic analysis of low-molecular-weight metabolites in biological samples and has become an important tool in clinical research and the diagnosis of human disease and has been applied to discovery and identification of the perturbed pathways. It provides a powerful approach to discover biomarkers in biological systems and offers a holistic approach with the promise to clinically enhance diagnostics. When carried out properly, it could provide insight into the understanding of the underlying mechanisms of diseases, help to identify patients at risk of disease, and predict the response to specific treatments. Currently, metabolomics has become an important tool in clinical research and the diagnosis of human disease and becomes a hot topic. This review will highlight the importance and benefit of metabolomics for identifying biomarkers that accurately screen potential biomarkers of diseases.</description><identifier>ISSN: 2314-6133</identifier><identifier>EISSN: 2314-6141</identifier><identifier>DOI: 10.1155/2015/354671</identifier><identifier>PMID: 26090402</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Advantages ; Bioinformatics ; Biological markers ; Biomarkers ; Biomedical Research ; Chromatography ; Disease ; Genotype &amp; phenotype ; Grants ; Health aspects ; Humans ; Mass spectrometry ; Medical diagnosis ; Metabolism ; Metabolites ; Metabolomics ; Observations ; Pathology ; Review ; Science ; Scientific imaging</subject><ispartof>BioMed research international, 2015-01, Vol.2015 (2015), p.1-6</ispartof><rights>Copyright © 2015 Aihua Zhang et al.</rights><rights>COPYRIGHT 2015 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2015 Aihua Zhang et al. Aihua Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2015 Aihua Zhang et al. 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c594t-b07b02b242a4bf5405e904d761af056a0bcaf072459580bad59d09f7ed4458b43</citedby><cites>FETCH-LOGICAL-c594t-b07b02b242a4bf5405e904d761af056a0bcaf072459580bad59d09f7ed4458b43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1684440267/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1684440267?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,25753,27924,27925,37012,37013,44590,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26090402$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Che, Fa-Yun</contributor><creatorcontrib>Wang, Ping</creatorcontrib><creatorcontrib>Yan, Guangli</creatorcontrib><creatorcontrib>Sun, Hui</creatorcontrib><creatorcontrib>Zhang, Aihua</creatorcontrib><creatorcontrib>Wang, Xijun</creatorcontrib><title>Metabolomics for Biomarker Discovery: Moving to the Clinic</title><title>BioMed research international</title><addtitle>Biomed Res Int</addtitle><description>To improve the clinical course of diseases, more accurate diagnostic and assessment methods are required as early as possible. In order to achieve this, metabolomics offers new opportunities for biomarker discovery in complex diseases and may provide pathological understanding of diseases beyond traditional technologies. It is the systematic analysis of low-molecular-weight metabolites in biological samples and has become an important tool in clinical research and the diagnosis of human disease and has been applied to discovery and identification of the perturbed pathways. It provides a powerful approach to discover biomarkers in biological systems and offers a holistic approach with the promise to clinically enhance diagnostics. When carried out properly, it could provide insight into the understanding of the underlying mechanisms of diseases, help to identify patients at risk of disease, and predict the response to specific treatments. Currently, metabolomics has become an important tool in clinical research and the diagnosis of human disease and becomes a hot topic. This review will highlight the importance and benefit of metabolomics for identifying biomarkers that accurately screen potential biomarkers of diseases.</description><subject>Advantages</subject><subject>Bioinformatics</subject><subject>Biological markers</subject><subject>Biomarkers</subject><subject>Biomedical Research</subject><subject>Chromatography</subject><subject>Disease</subject><subject>Genotype &amp; phenotype</subject><subject>Grants</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Mass spectrometry</subject><subject>Medical diagnosis</subject><subject>Metabolism</subject><subject>Metabolites</subject><subject>Metabolomics</subject><subject>Observations</subject><subject>Pathology</subject><subject>Review</subject><subject>Science</subject><subject>Scientific imaging</subject><issn>2314-6133</issn><issn>2314-6141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNqNkc1PGzEQxS1UBBFw6r1aqZcKFPB4be86h0oQPiUQl_Zs2bvexHSzTu1NEP89E4VGKaf4MiP55-d58wj5CvQcQIgLRkFc5ILLAvbIgOXAhxI4fNn0eX5ITlJ6oXhKkFTJA3LIsFJO2YCMnlxvbGjDzFcpa0LMrnyYmfjHxezapyosXXwbZU9h6btJ1oesn7ps3PrOV8dkvzFtcicf9Yj8vr35Nb4fPj7fPYwvH4eVULwfWlpYyizjzHDbCE6Fw7_rQoJpqJCG2gqbgnGhREmtqYWqqWoKV3MuSsvzI_JzrTtf2JmrK9f10bR6Hj3O-aaD8fr_m85P9SQsNb5nKIsCPz4EYvi7cKnXM3Tm2tZ0LiySBqmAlUoJvgtKGUiuCkS_f0JfwiJ2uAmkSs5xvXKLmpjWad81AUesVqL6Eu2BBGAMqbM1VcWQUnTNxh1QvcpZr3LW65yR_ra9kA37L1UETtfA1He1efW7qTlEXGO2YCGgoPk76Ge1oA</recordid><startdate>20150101</startdate><enddate>20150101</enddate><creator>Wang, Ping</creator><creator>Yan, Guangli</creator><creator>Sun, Hui</creator><creator>Zhang, Aihua</creator><creator>Wang, Xijun</creator><general>Hindawi Publishing Corporation</general><general>John Wiley &amp; Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150101</creationdate><title>Metabolomics for Biomarker Discovery: Moving to the Clinic</title><author>Wang, Ping ; Yan, Guangli ; Sun, Hui ; Zhang, Aihua ; Wang, Xijun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c594t-b07b02b242a4bf5405e904d761af056a0bcaf072459580bad59d09f7ed4458b43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Advantages</topic><topic>Bioinformatics</topic><topic>Biological markers</topic><topic>Biomarkers</topic><topic>Biomedical Research</topic><topic>Chromatography</topic><topic>Disease</topic><topic>Genotype &amp; phenotype</topic><topic>Grants</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Mass spectrometry</topic><topic>Medical diagnosis</topic><topic>Metabolism</topic><topic>Metabolites</topic><topic>Metabolomics</topic><topic>Observations</topic><topic>Pathology</topic><topic>Review</topic><topic>Science</topic><topic>Scientific imaging</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Ping</creatorcontrib><creatorcontrib>Yan, Guangli</creatorcontrib><creatorcontrib>Sun, Hui</creatorcontrib><creatorcontrib>Zhang, Aihua</creatorcontrib><creatorcontrib>Wang, Xijun</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Middle East &amp; Africa Database</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest advanced technologies &amp; aerospace journals</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BioMed research international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Ping</au><au>Yan, Guangli</au><au>Sun, Hui</au><au>Zhang, Aihua</au><au>Wang, Xijun</au><au>Che, Fa-Yun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolomics for Biomarker Discovery: Moving to the Clinic</atitle><jtitle>BioMed research international</jtitle><addtitle>Biomed Res Int</addtitle><date>2015-01-01</date><risdate>2015</risdate><volume>2015</volume><issue>2015</issue><spage>1</spage><epage>6</epage><pages>1-6</pages><issn>2314-6133</issn><eissn>2314-6141</eissn><abstract>To improve the clinical course of diseases, more accurate diagnostic and assessment methods are required as early as possible. In order to achieve this, metabolomics offers new opportunities for biomarker discovery in complex diseases and may provide pathological understanding of diseases beyond traditional technologies. It is the systematic analysis of low-molecular-weight metabolites in biological samples and has become an important tool in clinical research and the diagnosis of human disease and has been applied to discovery and identification of the perturbed pathways. It provides a powerful approach to discover biomarkers in biological systems and offers a holistic approach with the promise to clinically enhance diagnostics. When carried out properly, it could provide insight into the understanding of the underlying mechanisms of diseases, help to identify patients at risk of disease, and predict the response to specific treatments. Currently, metabolomics has become an important tool in clinical research and the diagnosis of human disease and becomes a hot topic. This review will highlight the importance and benefit of metabolomics for identifying biomarkers that accurately screen potential biomarkers of diseases.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>26090402</pmid><doi>10.1155/2015/354671</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2314-6133
ispartof BioMed research international, 2015-01, Vol.2015 (2015), p.1-6
issn 2314-6133
2314-6141
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4452245
source Wiley Online Library Open Access; Publicly Available Content Database
subjects Advantages
Bioinformatics
Biological markers
Biomarkers
Biomedical Research
Chromatography
Disease
Genotype & phenotype
Grants
Health aspects
Humans
Mass spectrometry
Medical diagnosis
Metabolism
Metabolites
Metabolomics
Observations
Pathology
Review
Science
Scientific imaging
title Metabolomics for Biomarker Discovery: Moving to the Clinic
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T08%3A49%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolomics%20for%20Biomarker%20Discovery:%20Moving%20to%20the%20Clinic&rft.jtitle=BioMed%20research%20international&rft.au=Wang,%20Ping&rft.date=2015-01-01&rft.volume=2015&rft.issue=2015&rft.spage=1&rft.epage=6&rft.pages=1-6&rft.issn=2314-6133&rft.eissn=2314-6141&rft_id=info:doi/10.1155/2015/354671&rft_dat=%3Cgale_pubme%3EA458161122%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c594t-b07b02b242a4bf5405e904d761af056a0bcaf072459580bad59d09f7ed4458b43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1684440267&rft_id=info:pmid/26090402&rft_galeid=A458161122&rfr_iscdi=true